Dr. Francis Burrows is an experienced biotech executive and serial bioentrepreneur. He was the VP of Biology at Conforma Therapeutics (discovery of Hsp90 inhibitors) acquired by Biogen-Idec, San Diego, and then the Senior Director of Discovery Oncology at Biogen-Idec. Dr. Burrows is currently VP of Translational Research at Kura Oncology.
Dr. Martha Knight is an experienced bioentrepreneur and expert in peptide therapeutic technology. She is currently CEO of CC Biotech LLC, a bioprocess technology company in Rockville, MD in collaboration with NIH. Dr. Knight founded and operated Peptide Technologies Corporation, a peptide synthesis and analytical chemistry company for 20 years in Maryland and Washington D.C.